Centerpoint Advisors, LLC
- SEC CIK
- 0001733788
- Latest filing
- Aug 5, 2026
RARE holding history
Ultragenyx Pharmaceutical Inc. in every 13F filed by Centerpoint Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RARE overviewAll 13F holders of RAREFull Q2 2026 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 2
- Since Q4 2021